this is the response i got from fidelity a few moments ago - no target date provided due to waiting on DTCC eligibility approval:
Fidelity Rep: I just spoke to my re-org department and originally we were anticipating it taking from 10-12 days. But, this is waiting on a DTCC eligibility approval and we do not have a solid date.
iAnthus Capital and MPX Bioceutical merge
iAnthus Capital Holdings, Inc. (ITHUF, CUSIP number: 45074T102) and MPX Bioceutical Corporation (CUSIP number: 553443102) announced that they have closed their previously announced plan of merger.
Important: The anticipated payable date has not been announced. The effective date was February 5. This was posted 2/13.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.